↓ Skip to main content

Dove Medical Press

Article Metrics

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

Overview of attention for article published in Vascular Health and Risk Management, November 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
36 Mendeley
Title
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
Published in
Vascular Health and Risk Management, November 2013
DOI 10.2147/vhrm.s49840
Pubmed ID
Authors

Joanne Foody, Peter Toth, Shiva Sajjan, Dena Ramey, David Neff, Andrew Tershakovec, Kaan Tunceli, Henry Hu, Joanne Tomassini

Abstract

Many high-risk coronary heart disease (CHD) patients on statin monotherapy do not achieve guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals, and combination lipid-lowering therapy may be considered for these individuals. The effect of adding ezetimibe to simvastatin, atorvastatin, or rosuvastatin therapy versus titrating these statins on LDL-C changes and goal attainment in CHD or CHD risk-equivalent patients was assessed in a large, managed-care database in the US.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 3%
Unknown 35 97%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 7 19%
Student > Master 6 17%
Student > Bachelor 5 14%
Researcher 5 14%
Other 2 6%
Other 6 17%
Unknown 5 14%
Readers by discipline Count As %
Medicine and Dentistry 11 31%
Pharmacology, Toxicology and Pharmaceutical Science 5 14%
Biochemistry, Genetics and Molecular Biology 3 8%
Agricultural and Biological Sciences 2 6%
Unspecified 1 3%
Other 5 14%
Unknown 9 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2013.
All research outputs
#2,328,989
of 4,505,915 outputs
Outputs from Vascular Health and Risk Management
#187
of 314 outputs
Outputs of similar age
#50,903
of 102,558 outputs
Outputs of similar age from Vascular Health and Risk Management
#16
of 19 outputs
Altmetric has tracked 4,505,915 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 314 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 102,558 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.